|

Relatilmab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Opdualag

Pipeline

Phase 1: 1

Top Sponsors

  • Washington University School of Medicine1

Indications

  • Advanced Melanoma1
  • Metastatic Melanoma1
  • Cancer1

St Louis, Missouri1 trial

Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

Washington University School of Medicine

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.